My Top Pharma Stocks to Buy in the Market Crash [The Motley Fool]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: The Motley Fool
The longest bull market in history, from 009 to early 00, is officially over. On March , the Dow Jones closed more than 0% down from its most recent high, officially crossing the border into bear market territory. It was bound to happen eventually. But it is worth noting that the catalyst for this market correction, the ongoing COVID-9 pandemic, may continue to get worse before it gets better. Furthermore, the outbreak could have a long-lasting impact on the economy.With this backdrop in mind, it is understandable why some investors would choose to keep their hard-earned cash in their pockets and refrain from buying stocks. But others may see the recent market crash as an opportunity to buy quality stocks for a discount. If you fall into the second category, here are twopharma stocksImage Source: Getty Images.Gilead Sciences: Leading the hunt for a COVID-9 treatment(NASDAQ:GILDclaimedThese clinical trials will take place primarily in China and other Asian countries, and the company wi
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Royal Bank of Canada from $76.00 to $74.00. They now have a "sector perform" rating on the stock.MarketBeat
- Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]Yahoo! Finance
- Merus (MRUS) Moves 7.1% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences, Inc. (NASDAQ: GILD) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
GILD
Earnings
- 4/25/24 - Beat
GILD
Sec Filings
- 4/25/24 - Form 8-K
- 4/2/24 - Form 4
- 4/1/24 - Form 144
- GILD's page on the SEC website